enzo biochem inc is a financial services company located in 60 executive blvd, farmingdale, new york, united states.
Company profile
Ticker
ENZ
Exchange
Website
CEO
Elazar Rabbani
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Enzo Clinical Labs, Inc. • Enzo Life Sciences, Inc. • Enzo Therapeutics, Inc. • Enzo Realty LLC • Enzo Realty II, LLC ...
IRS number
132866202
ENZ stock data
Latest filings (excl ownership)
8-K
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
13 Mar 24
10-Q
2024 Q2
Quarterly report
13 Mar 24
8-K
Departure of Directors or Certain Officers
27 Feb 24
8-K
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
1 Feb 24
DEFR14A
Revised proxy
21 Dec 23
ARS
2023 FY
Annual report to shareholders
21 Dec 23
10-Q
2024 Q1
Quarterly report
15 Dec 23
10-K/A
2023 FY
Annual report (amended)
28 Nov 23
10-K
2023 FY
Annual report
3 Nov 23
NT 10-K
Notice of late annual filing
30 Oct 23
Transcripts
ENZ
Earnings call transcript
2023 Q1
13 Dec 22
ENZ
Earnings call transcript
2022 Q4
14 Oct 22
ENZ
Earnings call transcript
2022 Q3
10 Jun 22
ENZ
Earnings call transcript
2022 Q2
15 Mar 22
ENZ
Earnings call transcript
2022 Q1
16 Dec 21
ENZ
Earnings call transcript
2021 Q4
12 Oct 21
ENZ
Earnings call transcript
2021 Q3
10 Jun 21
ENZ
Earnings call transcript
2021 Q2
16 Mar 21
ENZ
Earnings call transcript
2021 Q1
10 Dec 20
ENZ
Earnings call transcript
2020 Q4
13 Oct 20
Latest ownership filings
4
Kara Cannon
27 Feb 24
4
Patricia Eckert
27 Feb 24
SC 13G/A
1 MAIN CAPITAL MANAGEMENT, LLC
14 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
4
STEVEN J PULLY
2 Feb 24
4
MARY TAGLIAFERRI
2 Feb 24
4
Bradley Louis Radoff
2 Feb 24
4
STEVEN J PULLY
15 Dec 23
3
STEVEN J PULLY
30 Oct 23
SC 13G
1 MAIN CAPITAL MANAGEMENT, LLC
11 Sep 23
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jul 23 | Jul 22 | Jul 21 | Jul 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 69.21 mm | 69.21 mm | 69.21 mm | 69.21 mm | 69.21 mm | 69.21 mm |
Cash burn (monthly) | 4.72 mm | (no burn) | 1.89 mm | 1.71 mm | 4.46 mm | 3.47 mm |
Cash used (since last report) | 23.34 mm | n/a | 9.35 mm | 8.44 mm | 22.03 mm | 17.16 mm |
Cash remaining | 45.87 mm | n/a | 59.86 mm | 60.77 mm | 47.18 mm | 52.05 mm |
Runway (months of cash) | 9.7 | n/a | 31.6 | 35.6 | 10.6 | 15.0 |
Institutional ownership, Q2 2023
57.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 51 |
Opened positions | 5 |
Closed positions | 10 |
Increased positions | 9 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 29.49 bn |
Total shares | 29.31 mm |
Total puts | 12.50 k |
Total calls | 60.20 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Harbert Fund Advisors | 5.18 mm | $9.52 bn |
Harbert Discovery Fund | 5.18 mm | $17.03 mm |
LH Laboratory Corp. Of America | 4.86 mm | $5.79 mm |
Renaissance Technologies | 2.70 mm | $4.98 mm |
Tang Capital Management | 2.30 mm | $4.23 bn |
Vanguard | 1.73 mm | $3.18 bn |
Dimensional Fund Advisors | 1.27 mm | $2.33 bn |
Potomac Capital Management | 1.05 mm | $1.93 bn |
BLK Blackrock | 998.48 k | $1.84 bn |
Fuller & Thaler Asset Management | 985.66 k | $1.81 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Feb 24 | Patricia Eckert | Stock Option (to acquire shares of Common Stock) Common Stock | Grant | Acquire A | No | No | 1.38 | 75,000 | 103.50 k | 75,000 |
23 Feb 24 | Kara Cannon | Common Stock | Grant | Acquire A | No | No | 0 | 150,000 | 0.00 | 451,297 |
21 Feb 24 | Kara Cannon | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 5,823 | 0.00 | 301,297 |
21 Feb 24 | Kara Cannon | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,640 | 0.00 | 307,120 |
31 Jan 24 | Radoff Bradley Louis | Common Stock | Grant | Acquire A | No | No | 0 | 79,365 | 0.00 | 4,390,882 |
31 Jan 24 | Steven J Pully | Common Stock | Grant | Acquire A | No | No | 0 | 79,365 | 0.00 | 97,095 |
31 Jan 24 | Mary Tagliaferri | Common Stock | Grant | Acquire A | No | No | 0 | 79,365 | 0.00 | 312,383 |